Pilot Study of a Web-based Decision Tool on Post-operative Use of Radioactive Iodine. (Record no. 3304)

MARC details
000 -LEADER
fixed length control field 02447nam a22003017a 4500
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 180508s20172017 xxu||||| |||| 00| 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1758-3772
024 ## - OTHER STANDARD IDENTIFIER
Standard number or code 10.17925/EE.2017.13.01.26 [doi]
024 ## - OTHER STANDARD IDENTIFIER
Standard number or code PMC5813442 [pmc]
040 ## - CATALOGING SOURCE
Original cataloging agency Ovid MEDLINE(R)
099 ## - LOCAL FREE-TEXT CALL NUMBER (OCLC)
PMID 29632603
245 ## - TITLE STATEMENT
Title Pilot Study of a Web-based Decision Tool on Post-operative Use of Radioactive Iodine.
251 ## - Source
Source European Endocrinology. 13(1):26-29, 2017 Apr
252 ## - Abbreviated Source
Abbreviated source Eur Endocrinol. 13(1):26-29, 2017 Apr
253 ## - Journal Name
Journal name European endocrinology
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Year 2017
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Manufacturer FY2018
266 ## - Date added to catalog
Date added to catalog 2018-05-08
520 ## - SUMMARY, ETC.
Abstract <b>Background</b>: The Thyroid Cancer Care Collaborative developed a web-based clinical decision-making module (CDMM) to inform risk-adjusted decisions on post-thyroidectomy radioactive iodine (RAI) use in papillary thyroid cancer (PTC). <b>Methods</b>: In a pilot study, we evaluated the CDMM in 19 PTC cases representing low- (five), intermediate- (seven) and high-risk (seven) disease. Two PTC experts and 10 PTC physicians reviewed cases and assigned risk level and RAI recommendation. The experts used a standard approach while the others used the CDMM. We assessed agreement between responses using a weighted Kappa. <b>Results</b>: Between experts, risk-assignment was concordant in 100%, 57% and 86% of low-, intermediate- and high-risk cases, respectively. Between CDMM users, risk-assignment was concordant in 100%, 29% and 14% in low-, intermediate- and high-risk cases, respectively (p=0.01). CDMM-assigned risk agreed with the expert-assigned risk in 100%, 25% and 0% of low-, intermediate- and high-risk cases, respectively (Kappa=0.69). For RAI use, the experts agreed in 15 cases while CDMM users agreed in eight. On further analysis, interpretation of extrathyroidal extension and lymph node staging led to discrepancies with the CDMM. <b>Conclusions</b>: For a web-based CDMM to accurately inform appropriate use of RAI in PTC, standard pathological and surgical reports are necessary.
546 ## - LANGUAGE NOTE
Language note English
651 ## - SUBJECT ADDED ENTRY--GEOGRAPHIC NAME
Institution MedStar Washington Hospital Centereonard
656 ## - INDEX TERM--OCCUPATION
Department Medicine/Endocrinology
657 ## - INDEX TERM--FUNCTION
Medline publication type Journal Article
700 ## - ADDED ENTRY--PERSONAL NAME
Local Authors Wartofsky, Leonard
790 ## - Authors
All authors Baxi SS, Bickford C, Dewey E, Eaton A, Fish S, Kurtzman R, Michael Tuttle R, Wartofsky L
856 ## - ELECTRONIC LOCATION AND ACCESS
DOI <a href="https://dx.doi.org/10.17925/EE.2017.13.01.26">https://dx.doi.org/10.17925/EE.2017.13.01.26</a>
Public note https://dx.doi.org/10.17925/EE.2017.13.01.26
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Koha item type Journal Article
Item type description Article
Holdings
Withdrawn status Lost status Damaged status Not for loan Collection Home library Current library Date acquired Total Checkouts Full call number Barcode Date last seen Price effective from Koha item type
          MedStar Authors Catalog MedStar Authors Catalog 05/08/2018   29632603 29632603 05/08/2018 05/08/2018 Journal Article

Powered by Koha